Pathway Financial Advisers’s Eli Lilly LLY Stock Holding History

Pathway Financial Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.57M	Buy	2,791 +278	+11%	+$282K	0.73%	50
2025 Q4	$2.7M	Sell	2,513 -23	-0.9%	-$22K	0.78%	46
2025 Q3	$1.88M	Buy	2,536 +749	+42%	+$557K	0.55%	64
2025 Q2	$1.39M	Buy	1,787 +123	+7%	+$95.6K	0.45%	75
2025 Q1	$1.37M	Buy	1,664 +478	+40%	+$398K	0.47%	72
2024 Q4	$915K	Sell	1,186 -1,021,202	-100%	-$846M	0.31%	94
2024 Q3	$1.15K	Buy	1,022,388 +1,021,287	+92,760%	+$918M	﹤0.01%	371
2024 Q2	$982K	Buy	1,101 +44	+4%	+$35.2K	0.35%	90
2024 Q1	$823K	Buy	1,057 +82	+8%	+$58.4K	0.3%	99
2023 Q4	$568K	Buy	975 +99	+11%	+$57.8K	0.22%	114
2023 Q3	$471K	Buy	+876	New	+$451K	0.19%	118
2023 Q1	$323K	Sell	940 -250	-21%	-$84.3K	0.13%	139
2022 Q4	$436K	Buy	+1,190	New	+$422K	0.18%	119

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pathway Financial Advisers's LLY Position: Q1 2026 in Review

Pathway Financial Advisers increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $282K and bringing the position to 2,791 shares worth $2.57M. The position accounts for 0.73% of the portfolio, ranked #50.

Pathway Financial Advisers first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Pathway Financial Advisers held 2,791 shares of Eli Lilly worth $2.57M as of Q1 2026.
Pathway Financial Advisers bought 278 Eli Lilly shares in Q1 2026, an estimated $282K.
Eli Lilly made up 0.73% of Pathway Financial Advisers's portfolio in Q1 2026, its #50 holding.
Pathway Financial Advisers first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
Pathway Financial Advisers's Eli Lilly position peaked at $2.7M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pathway Financial Advisers's 13F filing for Q1 2026, filed 23 Apr 2026.